Imaging of gynecologic malignancies with FDG PET-CT: Case examples, physiolocic activity, and pitfalls

Abdominal Imaging

Volumn 34, Issue 6, 2009, Pages 696-711

  De Gaetano, Anna Maria ^a   Calcagni, Maria Lucia ^a   Rufini, Vittoria ^a   Valentini, Anna Lia ^a   Gui, Benedetta ^a   Giordano, Alessandro ^a   Bonomo, Lorenzo ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

FDG PET; Gynecologic malignancies; Pelvic malignancies; PET CT; Uterine cancer

Indexed keywords

CONTRAST MEDIUM;

ADVANCED CANCER; BLADDER; CANCER DIAGNOSIS; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ENDOMETRIUM CARCINOMA; FALSE POSITIVE RESULT; GYNECOLOGIC CANCER; HUMAN; HYSTERECTOMY; LYMPH NODE METASTASIS; METASTASIS; OVARY CANCER; PATIENT MONITORING; PELVIS LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; REVIEW; TREATMENT RESPONSE; URETER; UTERINE CERVIX CANCER; VAGINA CANCER; VULVA CANCER;

FEMALE; FLUORODEOXYGLUCOSE F18; GENITAL NEOPLASMS, FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 71449113901     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-008-9457-8     Document Type: Review

References (75)

1. RL Wahl 2004 Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT J Nucl Med 45 82S 95S 14736839
2. K Koyama T Okamura J Kawabe, et al. 2003 Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors J Nucl Med 44 3 353 358 12621000
3. Y Sugawara A Eisbruch S Kosuda, et al. 1999 Evaluation of FDG PET in patients with cervical cancer J Nucl Med 40 7 1125 1131 10405131
4. CH Lai KG Huang LC See, et al. 2004 Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-d-glucose positron emission tomography Cancer 100 3 544 552 10.1002/cncr.11928 14745871 (Pubitemid 38124772)
5. SK Kim KW Kang JW Roh, et al. 2005 Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle Eur J Nucl Med Mol Imaging 32 7 757 763 10.1007/s00259-005-1771-6 15772859 (Pubitemid 41125417)
6. S Nishizawa M Inubushi H Okada 2005 Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers Eur J Nucl Med Mol Imaging 32 5 549 556 10.1007/s00259-004-1703-x 15599527 (Pubitemid 41214197)
7. H Lerman U Metser D Grisaru, et al. 2004 Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT J Nucl Med 45 2 266 271 14960646
8. Hempling RE (1996) Handbook of gynecologic oncology, 2nd edn. Boston: Little Brown, pp 103-130
9. T Toita M Nakano M Higashi, et al. 1995 Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy Int J Radiat Oncol Biol Phys 33 4 843 849 7591892
10. TC Yen LC See CH Lai, et al. 2004 18F-FDG uptake in squmous cell carcinoma of the cervix is correlated with glucose transporter 1 expression J Nucl Med 45 1 22 29 14734665
11. V Nicolet L Carignan F Bourdon, et al. 2000 MR imaging of cervical carcinoma: a practical staging approach Radiographics 20 6 1539 1549 11112809
12. J Scheidler H Hricak KK Yu, et al. 1997 Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis JAMA 278 13 1096 1101 10.1001/jama.278.13.1096 9315770
13. Y Sugawara A Eisbruch S Kosuda, et al. 1999 Evaluation of FDG PET in patients with cervical cancer J Nucl Med 40 7 1125 1131 10405131
14. PG Rose LP Adler M Rodriguez, et al. 1999 Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study J Clin Oncol 17 1 41 45 10458216
15. MJ Reinhardt C Ehritt-Braun D Vogelgesang, et al. 2001 Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET Radiology 218 3 776 782 11230656
16. K Narayan RJ Hicks T Jobling, et al. 2001 A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment Int J Gynecol Cancer 11 4 263 271 10.1046/j.1525-1438.2001.011004263.x 11520363 (Pubitemid 32751393)
17. SS Sun TC Chen RF Yen, et al. 2001 Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer Anticancer Res 21 4B 2957 2961 11712793
18. LS Yeh YC Hung YY Shen, et al. 2002 Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings Oncol Rep 9 6 1289 1292 12375036
19. WC Lin YC Hung LS Yeh, et al. 2003 Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings Gynecol Oncol 89 1 73 76 10.1016/S0090-8258(03)00058-1 12694656 (Pubitemid 36403649)
20. SY Ma LC See CH Lai, et al. 2003 Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients J Nucl Med 44 11 1775 1783 14602859
21. LJ Havrilesky SL Kulasingam DB Matchar, et al. 2005 FDG-PET for management of cervical and ovarian cancer Gynecol Oncol 97 1 183 191 10.1016/j.ygyno.2004.12.007 15790456 (Pubitemid 40403692)
22. HJ Choi JW Roh SS Seo, et al. 2006 Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study Cancer 106 4 914 922 10.1002/cncr.21641 16411226 (Pubitemid 43238460)
23. JW Roh SS Seo S Lee, et al. 2005 Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study Eur J Cancer 41 14 2086 2092 10.1016/j.ejca.2005.05.013 16125928 (Pubitemid 41337950)
24. JD Wright F Dehdashti TJ Herzog, et al. 2005 Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-d-glucose- positron emission tomography Cancer 104 11 2484 2491 10.1002/cncr.21527 16270319 (Pubitemid 41691572)
25. TZ Wong EL Jones RE Coleman 2004 Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-d-glucose for evaluating local and distant disease in patients with cervical cancer Mol Imaging Biol 6 1 55 62 10.1016/j.mibio.2003. 12.004 15018829 (Pubitemid 38240359)
26. DiSaia PJ, Creasman WT (2002) Clinical gynecologic oncology, 6th edn. Mosby: St Louis
27. DH Park KH Kim SY Park 2000 Diagnosis of recurrent uterine cervical cancer: computed tomography versus positron emission tomography Korean J Radiol 1 1 51 55 10.3348/kjr.2000.1.1.51 11752929
28. SS Sun TC Chen RF Yen, et al. 2001 Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer Anticancer Res 21 4B 2957 2961 11712793
29. SY Ryu MH Kim SC Choi, et al. 2003 Detection of early recurrence with 18F-FDG PET in patients with cervical cancer J Nucl Med 44 3 347 352 12620999
30. Y Nakamoto A Eisbruch ED Achtyes, et al. 2002 Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy Gynecol Oncol 84 2 289 295 10.1006/gyno.2001.6504 11812089 (Pubitemid 34136782)
31. LJ Havrilesky TZ Wong AA Secord, et al. 2003 The role of PET scanning in the detection of recurrent cervical cancer Gynecol Oncol 90 1 186 90 10.1016/S0090-8258(03)00256-7 12821362 (Pubitemid 37338096)
32. CH Lai KG Huang LC See, et al. 2004 Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-d-glucose positron emission tomography Cancer 100 3 544 552 10.1002/cncr.11928 14745871 (Pubitemid 38124772)
33. PW Grigsby BA Siegel F Dehdashti 2001 Lymph node staging by positron emission tomography in patients with carcinoma of the cervix J Clin Oncol 19 17 3745 3749 11533097
34. NS Horowitz F Dehdashti TJ Herzog, et al. 2004 Prospective evaluation of FDG-PET for detecting pelvic ana paraortic lymph node matastasis in uterine corpus cancer Gynecol Oncol 95 3 546 551 10.1016/j.ygyno.2004.08.009 15581961 (Pubitemid 39592519)
35. SS Lentz 2002 Endometrial carcinoma diagnosed by positron emission tomography: a case report Gynecol Oncol 86 2 223 224 10.1006/gyno.2002.6718 12144832 (Pubitemid 34953508)
36. T Nakahara H Fujii M Ide, et al. 2001 F-18 FDG uptake in endometrial cancer Clin Nucl Med 26 1 82 83 10.1097/00003072-200101000-00028 11139071 (Pubitemid 32003200)
37. I Ak S Ozalp OT Yalcin E Zor, et al. 2004 Uptake of 2-[18F]fluoro-2- deoxy-d-glucose in uterine leiomyoma: imaging of four patients by coincidence positron emission tomography Nucl Med Commun 25 9 941 945 10.1097/00006231- 200409000-00012 15319600 (Pubitemid 39180287)
38. T Torizuka F Nakamura M Takekuma, et al. 2006 FDG PET for the assessment of myometrial infiltration in clinical stage I uterine corpus cancer Nucl Med Commun 27 6 481 487 10.1097/00006231-200606000-00002 16710101 (Pubitemid 44309708)
39. NS Horowitz F Dehdashti TJ Herzog, et al. 2004 Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer Gynecol Oncol 95 3 546 551 10.1016/j.ygyno.2004.08.009 15581961 (Pubitemid 39592519)
40. A Chao TC Chang KK Ng, et al. 2006 18F-FDG PET in the management of endometrial cancer Eur J Nucl Med Mol Imaging 33 1 36 44 10.1007/s00259-005- 1876-y 16167154 (Pubitemid 41785307)
41. T Belhocine C De Barsy R Hustinx, et al. 2002 Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma Eur J Nucl Med Mol Imaging 29 9 1132 1139 10.1007/s00259-002-0878-2 12192557 (Pubitemid 34985357)
42. T Saga T Higashi T Ishimori, et al. 2003 Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer Ann Nucl Med 17 3 197 203 10.1007/BF02990022 12846541
43. WT Lamoreaux PW Grigsby F Dehdashti, et al. 2005 FDG-PET evaluation of vaginal carcinoma Int J Radiat Oncol Biol Phys 62 3 733 737 15936553
44. DE Cohn F Dehdashti RK Gibb, et al. 2002 Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer Gynecol Oncol 85 1 179 184 10.1006/gyno.2002.6605 11925141 (Pubitemid 34304031)
45. Lin LL, Dehdashti F, Siegel BA, et al. (2007) PET and PET-CT of tumors of the female genital tract. In: von Schulthess GK (ed) Molecular anatomic imaging. PET-CT and SPECT-CT integrated modality imaging, 2nd edn. Philadelphia: Lippincott Williams & Wilkins, pp 427-442
46. K Kawahara Y Yoshida T Kurokawa, et al. 2004 Evaluation of positron emission tomography with tracer 18-fluorodeoxyglucose in addition to magnetic resonance imaging in the diagnosis of ovarian cancer in selected women after ultrasonography J Comput Assist Tomogr 28 4 505 516 10.1097/00004728-200407000- 00011 15232382 (Pubitemid 38988818)
47. R Kumar A Alavi 2004 PET imaging in gynecologic malignancies Radiol Clin N Am 42 6 1155 1167 10.1016/j.rcl.2004.08.006 15488564 (Pubitemid 39361466)
48. KF Hubner TW McDonald JG Niethammer, et al. 1993 Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG) Gynecol Oncol 51 2 197 204 10.1006/gyno.1993. 1272 8276294
49. W Romer N Avril J Dose, et al. 1997 Metabolic characterization of ovarian tumors with positron-emission tomography and F-18 fluorodeoxyglucose Rofo 166 1 62 68 9072107
50. W Schroder M Zimny C Rudlowski, et al. 1999 The role of 18F-fluoro-deoxyglucose positron emission tomography (18F-FDG PET) in diagnosis of ovarian cancer Int J Gynecol Cancer 9 2 117 122 10.1046/j.1525-1438.1999. 09903.x 11240752 (Pubitemid 29220748)
51. D Grab F Flock I Stohr, et al. 2000 Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography Gynecol Oncol 77 3 454 459 10.1006/gyno.2000.5768 10831359 (Pubitemid 30368567)
52. G Lieberman AB MacLean JR Buscombe, et al. 2001 The clinical application of a dual head gamma camera with coincidence detection in 20 women with suspected ovarian cancer BJOG 108 12 1229 1236 10.1016/S0306-5456(01)00290-X 11843384 (Pubitemid 34076733)
53. S Fenchel D Grab K Nuessle, et al. 2002 Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings Radiology 223 3 780 788 10.1148/radiol.2233001850 12034950
54. K Kawahara Y Yoshida T Kurokawa, et al. 2004 Evaluation of positron emission tomography with tracer 18-fluorodeoxyglucose in addition to magnetic resonance imaging in the diagnosis of ovarian cancer in selected women after ultrasonography J Comput Assist Tomogr 28 4 505 516 10.1097/00004728-200407000- 00011 15232382 (Pubitemid 38988818)
55. Zimny M (2004) Ovarian cancer. In: Oehr P, Biersack HJ, Coleman RE (eds) PET and PET-CT in oncology. Berlin: Springer-Verlag, pp 227-235
56. RA Kubik-Huch W Dorffler GK von Schulthess, et al. 2000 Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma Eur Radiol 10 5 761 767 10.1007/s003300051000 10823629 (Pubitemid 30321087)
57. RF Yen SS Sun YY Shen, et al. 2001 Whole body positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer Anticancer Res 21 5 3691 3694 11848544
58. M Zimny W Siggelkow W Schroder, et al. 2001 2-[Fluorine-18]-fluoro-2- deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer Gynecol Oncol 83 2 310 315 10.1006/gyno.2001.6386 11606090 (Pubitemid 33033072)
59. SM Cho HK Ha JY Byun, et al. 2002 Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer AJR Am J Roentgenol 179 2 391 395 12130439
60. WC Chang YC Hung CH Kao, et al. 2002 Usefulness of whole body positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) to detect recurrent ovarian cancer based on asymptomatically elevated serum levels of tumor marker Neoplasma 49 5 329 333 12458332
61. T Torizuka S Nobezawa T Kanno, et al. 2002 Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2- deoxy-D-glucose Eur J Nucl Med Mol Imaging 29 6 797 803 10.1007/s00259-001-0750- 9 12029554
62. RE Bristow MG del Carmen HK Pannu, et al. 2003 Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT Gynecol Oncol 90 3 519 528 10.1016/S0090-8258(03)00336-6 13678719
63. HK Pannu C Cohade RE Bristow, et al. 2004 PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation Abdom Imaging 29 3 398 403 10.1007/s00261-003-0118-7 15354347
64. C Nanni D Rubello M Farsad, et al. 2005 (18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients Eur J Surg Oncol 31 7 792 797 10.1016/j.ejso.2005.02.029 15893908 (Pubitemid 41194659)
65. M Takekuma M Maeda T Ozawa, et al. 2005 Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer Int J Clin Oncol 10 3 177 181 10.1007/s10147-005-0489-6 15990965 (Pubitemid 40933691)
66. HK Pannu RE Bristow C Cohade, et al. 2004 PET-CT in recurrent ovarian cancer: initial observations Radiographics 24 1 209 223 10.1148/rg.241035078 14730047
67. LJ Havrilesky SL Kulasingam DB Matchar, et al. 2005 FDG-PET for management of cervical and ovarian cancer Gynecol Oncol 97 1 183 191 10.1016/j.ygyno.2004.12.007 15790456 (Pubitemid 40403692)
68. MJ Garcia Velloso JF Boan Garcia LM Villar Luque, et al. 2003 F-18-FDG positron emission tomography in the diagnosis of ovarian recurrence. Comparison with CT scan and CA 125 Rev Esp Med Nucl 22 4 217 223 12846945
69. B Simcock D Neesham M Quinn, et al. 2006 The impact of PET/CT in the management of recurrent ovarian cancer Gynecol Oncol 103 1 271 276 10.1016/j.ygyno.2006.03.004 16626793 (Pubitemid 44374699)
70. N Avril S Sassen B Schmalfeldt, et al. 2005 Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer J Clin Oncol 23 30 7445 7453 10.1200/JCO.2005.06.965 16157939 (Pubitemid 46291806)
71. MA Blake A Singh BN Setty, et al. 2006 Pearls and pitfalls in interpretation of abdominal and pelvic PET-CT Radiographics 26 5 1335 1353 10.1148/rg.265055208 16973768 (Pubitemid 44518767)
72. C Cohade M Osman Y Nakamoto, et al. 2003 Initial experience with oral contrast in PET-CT: phantom and clinical studies J Nucl Med 44 3 412 416 12621008
73. G Antoch LS Freudenberg T Egelhof, et al. 2002 Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET-CT scans J Nucl Med 43 10 1339 1342 12368372
74. YY Yau WS Chan YM Tam, et al. 2005 Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? J Nucl Med 46 2 283 291 15695788
75. N Subhas PV Patel HK Pannu, et al. 2005 Imaging of pelvic malignancies with in-line FDG PET-CT: case examples and common pitfalls of FDG PET Radiographics 25 4 1031 1043 10.1148/rg.254045155 16009822